Feb 14, 2023 | FDA, Featured
Patients Rising Now submitted comments to the Food and Drug Administration (FDA) on making naloxone available as an over-the-counter treatment. Naloxone is a treatment which prevents death in the event of an opioid overdose and is currently only available through...
Read more
Feb 13, 2023 | Featured, Letters Supported
Patients Rising Now joined 58 other organizations in a letter sent to the Centers for Medicare and Medicaid (CMS) on reinstating a Federal Rule prohibiting step therapy in Medicare Advantage plans. In 2012, CMS instituted a prohibition on step therapy in Medicare...
Read more
Feb 10, 2023 | Featured, QALY, Uncategorized
Patients Rising Now sent a letter to the Equal Employment Opportunity Commission (EEOC) regarding the release of its draft Strategic Enforcement Plan (SEP). The draft SEP outlined several new policy changes to enhance protections for employees from vulnerable...
Read more
Feb 2, 2023 | Comment Letters, Featured
Patients Rising Now joined 71 other organizations in signing on to a letter sent to HHS on the Notice of Benefits and Payment Parameters (NBPP) proposed rule for 2024. The proposed rule would increase access to health services under their current plans, improve the...
Read more
Jan 23, 2023 | Access, Featured
By Surabhi Dangi-Garimella, Ph.D. Hospital closures, service cuts, and lack of medical care in some of the poorest neighborhoods in the state—that is the status of hospitals and medical care in Mississippi, where 38 rural hospitals (54%) are expected to shutter their...
Read more
Jan 3, 2023 | Featured, Pharmacy Benefit Managers
By Surabhi Dangi-Garimella, Ph.D. Cigna’s pharmacy benefit manager (PBM), Express Scripts, has introduced network changes that have reduced the number of retail pharmacies within the Department of Defense (DoD)’s TRICARE benefits program by 15,000. Many of these are...
Read more
